6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial
- 1 March 1999
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 353 (9155) , 786-792
- https://doi.org/10.1016/s0140-6736(98)11046-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trialThe Lancet, 1999
- International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infectionThe Lancet, 1998
- Prevention of mother-to-child transmission of HIV in AfricaAIDS, 1998
- HIV, maternal anemia and perinatal intervention using zidovudineInternational Journal of Gynecology & Obstetrics, 1998
- Controversial Trial Offers Hopeful ResultScience, 1998
- Zidovudine and Breast-FeedingAIDS Patient Care and STDs, 1997
- Acceptability of Interventions to Reduce Mother-to-Child Transmission of HIV-1 in West AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Postnatal transmission of human immunodeficiency virus type 1: The breast-feeding dilemmaAmerican Journal of Obstetrics and Gynecology, 1995
- Zidovudine to decrease mother-to-child transmission of HIV-1: is it good for developing countries?AIDS, 1995
- Zidovudine to decrease mother-to-child transmission of HIV-1: is it good for developing countries?AIDS, 1995